Close Menu

NEW YORK (GenomeWeb) – MDxHealth reported Thursday that its total full-year 2017 revenues rose 35 percent, led by sales of its ConfirmMDx for prostate cancer test, which accounted for 91 percent of sales volumes.

For the 12 months ended Dec. 31, the company reported total revenues of $40.5 million, up from $30.0 million in 2016. Revenue included the sale of the company's colorectal cancer patents to Exact Sciences. Excluding revenue from that sale for both periods, total products and services revenue rose approximately 13 percent to $28.2 million during 2017.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A UK woman is suing three National Health Service Trusts for not telling her about her father's Huntington's disease diagnosis, the BBC reports.

LiveScience reports that a novel mutation in the LPL gene was uncovered in three siblings with very high triglyceride levels.

The president of Nankai University is embroiled in a data manipulation scandal, the South China Morning Post reports.

In PNAS this week: cytotoxic CD4 T cell signature in supercentenarians, evolutionary history of beetles, and more.